{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:17:02Z","timestamp":1772500622823,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-01302 and 2020-06116"],"award-info":[{"award-number":["2019-01302 and 2020-06116"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101003650"],"award-info":[{"award-number":["101003650"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"DOI":"10.1038\/s41435-024-00270-x","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T17:02:33Z","timestamp":1712163753000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines"],"prefix":"10.1038","volume":"25","author":[{"given":"Melissa","family":"Garc\u00eda-Vega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Res\u00e9ndiz-Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Hinojosa-Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-4569","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Mata-Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy","family":"Dehesa-Canseco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Sol\u00eds-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Marcotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-8804","authenticated-orcid":false,"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3600","authenticated-orcid":false,"given":"Jes\u00fas","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"270_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403\u201316.","journal-title":"N Engl J Med"},{"key":"270_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc2032195","volume":"384","author":"AT Widge","year":"2021","unstructured":"Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. N Engl J Med. 2021;384:80\u20132.","journal-title":"N Engl J Med"},{"key":"270_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-021-04117-7","volume":"600","author":"E Andreano","year":"2021","unstructured":"Andreano E, Paciello I, Piccini G, Manganaro N, Pileri P, Hyseni I, et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021;600:530\u20135.","journal-title":"Nature"},{"key":"270_CR4","doi-asserted-by":"publisher","first-page":"eabp8328","DOI":"10.1126\/sciimmunol.abp8328","volume":"7","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tong P, Whiteman N, Moghaddam AS, Zarghami M, Zuiani A, et al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Sci Immunol. 2022;7:eabp8328.","journal-title":"Sci Immunol"},{"key":"270_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1126\/science.abg9175","volume":"372","author":"L Stamatatos","year":"2021","unstructured":"Stamatatos L, Czartoski J, Wan YH, Homad LJ, Rubin V, Glantz H, et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science. 2021;372:1413\u20138.","journal-title":"Science"},{"key":"270_CR6","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1126\/science.abh1282","volume":"372","author":"CJ Reynolds","year":"2021","unstructured":"Reynolds CJ, Pade C, Gibbons JM, Butler DK, Otter AD, Menacho K, et al. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science. 2021;372:1418\u201323.","journal-title":"Science"},{"key":"270_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-022-01715-4","volume":"28","author":"PR Wratil","year":"2022","unstructured":"Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E, et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med. 2022;28:496\u2013503.","journal-title":"Nat Med"},{"key":"270_CR8","doi-asserted-by":"crossref","unstructured":"Gelanew T, Mulu A, Abebe M, Bates TA, Wassie L, Tefer M, et al. A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naive individuals. Vaccines. 2022;10:859.","DOI":"10.3390\/vaccines10060859"},{"key":"270_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/vaccines10050656","volume":"10","author":"S Guzman-Lopez","year":"2022","unstructured":"Guzman-Lopez S, Darwich-Salazar A, Bocanegra-Ibarias P, Salas-Trevino D, Flores-Trevino S, Perez-Alba E, et al. Clinical and immunologic efficacy of the recombinant adenovirus Type-5-Vectored (CanSino Bio) vaccine in university professors during the COVID-19 delta wave. Vaccines. 2022;10:656.","journal-title":"Vaccines"},{"key":"270_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41421-021-00300-2","volume":"7","author":"Q Cao","year":"2021","unstructured":"Cao Q, Wu S, Xiao C, Chen S, Chi X, Cui X, et al. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization. Cell Discov. 2021;7:64.","journal-title":"Cell Discov"},{"key":"270_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102125","volume":"50","author":"S Xiaojie","year":"2020","unstructured":"Xiaojie S, Yu L, Lei Y, Guang Y, Min Q. Neutralizing antibodies targeting SARS-CoV-2 spike protein. Stem Cell Res. 2020;50:102125.","journal-title":"Stem Cell Res"},{"key":"270_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-020-00287-4","volume":"5","author":"F Fagiani","year":"2020","unstructured":"Fagiani F, Catanzaro M, Lanni C. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2. Signal Transduct Target Ther. 2020;5:170.","journal-title":"Signal Transduct Target Ther"},{"key":"270_CR13","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.e29.","journal-title":"Cell."},{"key":"270_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding N, Bormann NL, Kraus G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res. 2020;9:47.","journal-title":"F1000Res"},{"key":"270_CR15","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1038\/s41596-021-00536-y","volume":"16","author":"KR Bewley","year":"2021","unstructured":"Bewley KR, Coombes NS, Gagnon L, McInroy L, Baker N, Shaik I, et al. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays. Nat Protoc. 2021;16:3114\u201340.","journal-title":"Nat Protoc"},{"key":"270_CR16","doi-asserted-by":"publisher","first-page":"e734","DOI":"10.1111\/tbed.14344","volume":"69","author":"EA Melgoza-Gonzalez","year":"2022","unstructured":"Melgoza-Gonzalez EA, Hinojosa-Trujillo D, Resendiz-Sandoval M, Mata-Haro V, Hernandez-Valenzuela S, Garcia-Vega M, et al. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines. Transbound Emerg Dis. 2022;69:e734\u201345.","journal-title":"Transbound Emerg Dis"},{"key":"270_CR17","doi-asserted-by":"publisher","first-page":"eabn8014","DOI":"10.1126\/sciimmunol.abn8014","volume":"7","author":"TA Bates","year":"2022","unstructured":"Bates TA, McBride SK, Leier HC, Guzman G, Lyski ZL, Schoen D, et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci Immunol. 2022;7:eabn8014.","journal-title":"Sci Immunol"},{"key":"270_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41392-023-01447-y","volume":"8","author":"J Hern\u00e1ndez","year":"2023","unstructured":"Hern\u00e1ndez J, Dehesa-Canseco F, V\u00e1zquez-L\u00f3pez AB, Res\u00e9ndiz-Sandoval M, Caire-Juvera G, Sol\u00eds-Hern\u00e1ndez M, et al. Neutralization of Omicron BA.1, BA.5.1.6, BQ.1.3 and XBB1.1 induced by heterologous vaccination Ad5-nCoV and mRNA-1273. Signal Transduct Target Ther. 2023;8:174.","journal-title":"Signal Transduct Target Ther"},{"key":"270_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.medj.2021.02.001","volume":"2","author":"N Sherina","year":"2021","unstructured":"Sherina N, Piralla A, Du L, Wan H, Kumagai-Braesch M, Andr\u00e9ll J, et al. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection. Med. 2021;2:281\u201395.e4.","journal-title":"Med"},{"key":"270_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103743","volume":"25","author":"H Marcotte","year":"2022","unstructured":"Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, et al. Immunity to SARS-CoV-2 up to 15 months after infection. iScience. 2022;25:103743.","journal-title":"iScience"},{"key":"270_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-021-00610-7","volume":"6","author":"B He","year":"2021","unstructured":"He B, Liu S, Wang Y, Xu M, Cai W, Liu J, et al. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. Signal Transduct Target Ther. 2021;6:195.","journal-title":"Signal Transduct Target Ther"},{"key":"270_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.20041185","volume":"200","author":"Y Nie","year":"2004","unstructured":"Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med. 2004;200:1145\u201356.","journal-title":"J Exp Med"},{"key":"270_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.humimm.2021.10.007","volume":"83","author":"H Xiang","year":"2022","unstructured":"Xiang H, Zhao Y, Li X, Liu P, Wang L, Wang M, et al. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients. Hum Immunol. 2022;83:119\u201329.","journal-title":"Hum Immunol"},{"key":"270_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan M, Wu NC, Zhu X, Lee CD, So RTY, Lv H, et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368:630\u20133.","journal-title":"Science"},{"key":"270_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.chom.2021.04.005","volume":"29","author":"H Liu","year":"2021","unstructured":"Liu H, Yuan M, Huang D, Bangaru S, Zhao F, Lee CD, et al. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe. 2021;29:806\u201318.e6.","journal-title":"Cell Host Microbe"},{"key":"270_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","volume":"6","author":"W Wen","year":"2020","unstructured":"Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31.","journal-title":"Cell Discov"},{"key":"270_CR27","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3389\/fimmu.2018.02987","volume":"9","author":"V Kalia","year":"2018","unstructured":"Kalia V, Sarkar S. Regulation of effector and memory CD8 T cell differentiation by IL-2-A balancing act. Front Immunol. 2018;9:2987.","journal-title":"Front Immunol"},{"key":"270_CR28","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.4049\/jimmunol.1000818","volume":"185","author":"N Yeh","year":"2010","unstructured":"Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, Hamada H, et al. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol. 2010;185:2089\u201398.","journal-title":"J Immunol"},{"key":"270_CR29","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","volume":"182","author":"H Hamada","year":"2009","unstructured":"Hamada H, de la Luz Garcia-Hernandez M, Reome JB, Misra SK, Strutt TM, McKinstry KK, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469\u201381.","journal-title":"J Immunol"},{"key":"270_CR30","doi-asserted-by":"publisher","first-page":"eabg5021","DOI":"10.1126\/sciimmunol.abg5021","volume":"6","author":"S Notarbartolo","year":"2021","unstructured":"Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, et al. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol. 2021;6:eabg5021.","journal-title":"Sci Immunol"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-024-00270-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-024-00270-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-024-00270-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T07:05:47Z","timestamp":1713337547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-024-00270-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1038\/s41435-024-00270-x","relation":{},"ISSN":["1476-5470"],"issn-type":[{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}